All In MedTech

FDA Clearance Tracker · P040044-S078

MynxGrip and Mynx Ace Vascular Closure Device

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 16, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 16, 2018

Approved

Time to decision

361 days

Received Nov 20, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P040044-S078
Device name
MynxGrip and Mynx Ace Vascular Closure Device
Applicant location
Miami Lakes, FL
Received
Nov 20, 2017
Decided
Nov 16, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P040044

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MGB

FDA's approval statement

As written in FDA's record.

Approval to add a new vendor for the hydrogel sealant components and to extend the shelf life of the hydrogel component to 25 months.

Source documents

Other decisions for Cordis US Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.